Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Institutional National Research Service Award (T32)
Project #
2T32CA009434-05
Application #
3533195
Study Section
Cancer Institutional Fellowship Review Committee (CT)
Project Start
1983-07-01
Project End
1992-06-30
Budget Start
1987-07-28
Budget End
1988-06-30
Support Year
5
Fiscal Year
1987
Total Cost
Indirect Cost
Name
University of Texas Health Science Center San Antonio
Department
Type
Schools of Medicine
DUNS #
800772162
City
San Antonio
State
TX
Country
United States
Zip Code
78229
Beuten, Joke; Garcia, Dawn; Brand, Timothy C et al. (2009) Semaphorin 3B and 3F single nucleotide polymorphisms are associated with prostate cancer risk and poor prognosis. J Urol 182:1614-20
Drengler, R L; Kuhn, J G; Schaaf, L J et al. (1999) Phase I and pharmacokinetic trial of oral irinotecan administered daily for 5 days every 3 weeks in patients with solid tumors. J Clin Oncol 17:685-96
Hidalgo, M; Rodriguez, G; Kuhn, J G et al. (1998) A Phase I and pharmacological study of the glutamine antagonist acivicin with the amino acid solution aminosyn in patients with advanced solid malignancies. Clin Cancer Res 4:2763-70
Hammond, L A; Eckardt, J R; Ganapathi, R et al. (1998) A phase I and translational study of sequential administration of the topoisomerase I and II inhibitors topotecan and etoposide. Clin Cancer Res 4:1459-67
McGuire, S E; Hilsenbeck, S G; Figueroa, J A et al. (1994) Detection of insulin-like growth factor binding proteins (IGFBPs) by ligand blotting in breast cancer tissues. Cancer Lett 77:25-32
Rodriguez, G (1994) Fludarabine phosphate. A new anticancer drug with significant activity in patients with chronic lymphocytic leukemia and in patients with lymphoma. Invest New Drugs 12:75-92
Krywicki, R F; Figueroa, J A; Jackson, J G et al. (1993) Regulation of insulin-like growth factor binding proteins in ovarian cancer cells by oestrogen. Eur J Cancer 29A:2015-9
Figueroa, J A; Jackson, J G; McGuire, W L et al. (1993) Expression of insulin-like growth factor binding proteins in human breast cancer correlates with estrogen receptor status. J Cell Biochem 52:196-205
McGuire Jr, W L; Jackson, J G; Figueroa, J A et al. (1992) Regulation of insulin-like growth factor-binding protein (IGFBP) expression by breast cancer cells: use of IGFBP-1 as an inhibitor of insulin-like growth factor action. J Natl Cancer Inst 84:1336-41
Harris, G J; Clark, G M; Von Hoff, D D (1992) Hispanic patients with head and neck cancer do not have a worse prognosis than Anglo-American patients. Cancer 69:1003-7

Showing the most recent 10 out of 26 publications